Newly Emergent Acquired EGFR Exon 18 G724S Mutation After Resistance of a T790M Specific EGFR Inhibitor Osimertinib in Non-Small-Cell Lung Cancer: A Case Report
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s188612
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Informa UK Limited